GENFIT Announces Corporate Updates and Upcoming Participation at The Liver Meeting® 2024
PBC program (licensed to Ipsen): Ipsen to present new data on elafibranor at The Liver Meeting® 2024 Launch of Iqirvo® (elafibranor)1 on track with expectations; encouraging feedback from healthcare providers and payers in the U.S. UK NICE reimbursement …